This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Shelar, S. et al. Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancer. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-18-1727 (2018)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bradley, C.A. Oncometabolite mechanism unravelled. Nat Rev Urol 15, 656–657 (2018). https://doi.org/10.1038/s41585-018-0086-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-018-0086-x